cifenline has been researched along with Andersen Syndrome in 1 studies
Andersen Syndrome: A form of inherited long QT syndrome (or LQT7) that is characterized by a triad of potassium-sensitive periodic paralysis, VENTRICULAR ECTOPIC BEATS, and abnormal features such as short stature, low-set ears, and SCOLIOSIS. It results from mutations of KCNJ2 gene which encodes a channel protein (INWARD RECTIFIER POTASSIUM CHANNELS) that regulates resting membrane potential.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuramoto, Y | 1 |
| Furukawa, Y | 1 |
| Yamada, T | 1 |
| Okuyama, Y | 1 |
| Fukunami, M | 1 |
1 other study available for cifenline and Andersen Syndrome
| Article | Year |
|---|---|
Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias.
Topics: Adult; Andersen Syndrome; Anti-Arrhythmia Agents; Death, Sudden, Cardiac; Defibrillators, Implantabl | 2012 |